These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9491162)

  • 1. Use of recombinant tissue-plasminogen activator for aortic thrombolysis in a hypoproteinemic dog.
    Clare AC; Kraje BJ
    J Am Vet Med Assoc; 1998 Feb; 212(4):539-43. PubMed ID: 9491162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of streptokinase in four dogs with thrombosis.
    Ramsey CC; Burney DP; Macintire DK; Finn-Bodner S
    J Am Vet Med Assoc; 1996 Aug; 209(4):780-5. PubMed ID: 8756879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant tissue plasminogen activator.
    Bell SG
    Neonatal Netw; 1996 Sep; 15(6):13-8. PubMed ID: 8932068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probable recurrent femoral artery thrombosis in a dog with intestinal lymphosarcoma.
    Ihle SL; Baldwin CJ; Pifer SM
    J Am Vet Med Assoc; 1996 Jan; 208(2):240-2. PubMed ID: 8567381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of a catheter-related right atrial thrombosis with recombinant tissue plasminogen activator and heparin.
    Cesaro S; Paris M; Corrò R; Svaluto G; Zanon GF; Gamba P; Milanesi O; Messina C; Zanesco L
    Support Care Cancer; 2002 Apr; 10(3):253-5. PubMed ID: 11904791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of carboxypeptidase U (TAFIa) activity improves rt-PA induced thrombolysis in a dog model of coronary artery thrombosis.
    Björkman JA; Abrahamsson TI; Nerme VK; Mattsson CJ
    Thromb Res; 2005; 116(6):519-24. PubMed ID: 16181987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Does the result of thrombolysis with recombinant tissue-type plasminogen activator (rt-PA) in rabbits depend on the erythrocyte- and fibrin-content of a thrombus?].
    Kirchhof K; Sikinger M; Welzel T; Zoubaa S; Sartor K
    Rofo; 2004 Jan; 176(1):98-105. PubMed ID: 14712413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical use of tissue plasminogen activator for systemic thrombolysis in dogs and cats.
    Diaz DM; Scansen BA; Lake Z; Shropshire S; Orton EC; Guillaumin J
    J Vet Cardiol; 2022 Jun; 41():154-164. PubMed ID: 35364502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein-losing enteropathies in dogs.
    Dossin O; Lavoué R
    Vet Clin North Am Small Anim Pract; 2011 Mar; 41(2):399-418. PubMed ID: 21486643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mobile thrombus in the right atrium and pulmonary embolism: efficacy of thrombolytic treatment with alteplase].
    López-Haldón JE; Varela Aguilar JM; Martínez Martínez A; González de la Puente MA
    Med Clin (Barc); 1997 Feb; 108(5):198. PubMed ID: 9091727
    [No Abstract]   [Full Text] [Related]  

  • 11. Dissolution of Urinary Bladder Clots in a Dog with Alteplase.
    Pineda C; Guisado A; Aguilera-Tejero E; Lopez I
    J Vet Intern Med; 2015; 29(6):1627-8. PubMed ID: 26455583
    [No Abstract]   [Full Text] [Related]  

  • 12. Plasmin induces local thrombolysis without causing hemorrhage: a comparison with tissue plasminogen activator in the rabbit.
    Marder VJ; Landskroner K; Novokhatny V; Zimmerman TP; Kong M; Kanouse JJ; Jesmok G
    Thromb Haemost; 2001 Sep; 86(3):739-45. PubMed ID: 11583303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of recombinant tissue-plasminogen activator in a dog with chylothorax secondary to catheter-associated thrombosis of the cranial vena cava.
    Bliss SP; Bliss SK; Harvey HJ
    J Am Anim Hosp Assoc; 2002; 38(5):431-5. PubMed ID: 12220027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolytic therapy for pulmonary embolism: is it effective? Is it safe? When is it indicated?
    Dalen JE; Alpert JS; Hirsh J
    Arch Intern Med; 1997 Dec 8-22; 157(22):2550-6. PubMed ID: 9531222
    [No Abstract]   [Full Text] [Related]  

  • 15. [Fibrinolytic therapy--plasminogen activator inhibitors].
    Hönigl K; Pilger E; Stark G; Bertuch H
    Vasa Suppl; 1988; 26():103-6. PubMed ID: 3144048
    [No Abstract]   [Full Text] [Related]  

  • 16. Intravitreal tissue plasminogen activator in submacular haemorrhage.
    Singh P; Singh R; Kishore KS; Vig VK; Singh R; Singh B
    Indian J Ophthalmol; 1999 Dec; 47(4):254-5. PubMed ID: 10892486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local intravenous thrombolysis with recombinant tissue plasminogen activator for salvage of forearm replantation.
    Hashim HA; Atiyeh BS; Hamdan AM; Musharrafieh RS
    J Reconstr Microsurg; 1996 Nov; 12(8):543-6. PubMed ID: 8951123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The tissue-type plasminogen activator story.
    Collen D; Lijnen HR
    Arterioscler Thromb Vasc Biol; 2009 Aug; 29(8):1151-5. PubMed ID: 19605778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Local thrombolysis with recombinant tissue plasminogen activator for thrombosed vascular access in hemodialysis patients.
    Vlassopoulos D; Logothetis E; Arvanitis D; Noussias C; Magana P; Katopodis K; Hadjiconstantinou V
    Clin Nephrol; 1996 Jul; 46(1):77-8. PubMed ID: 8832159
    [No Abstract]   [Full Text] [Related]  

  • 20. Thrombolysis with recombinant tissue plasminogen activator in atherosclerotic thrombotic occlusion.
    Topol EJ; Ciuffo AA; Pearson TA; Dillman J; Builder S; Grossbard E; Weisfeldt ML; Bulkley BH
    J Am Coll Cardiol; 1985 Jan; 5(1):85-91. PubMed ID: 4038373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.